PITTSBURGH, Sept. 28, 2020 (GLOBE NEWSWIRE) — NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating […]
Company Drives Another Year of Profitability Amidst Challenging Market ConditionsIntroduction of Global Subscription Pricing Model, Key Hires and Strong Initial […]